Display options
Cite
Levine H, Sepulveda-Beltran PA, Amescua G. Rose Bengal Photodynamic Antimicrobial Therapy as potential adjuvant treatment for Serratia marcescens corneal ulcer. Am J Ophthalmol. 2021;231:e1-e2doi: 10.1016/j.ajo.2021.07.007.
Levine, H., Sepulveda-Beltran, P. A., & Amescua, G. (2021). Rose Bengal Photodynamic Antimicrobial Therapy as potential adjuvant treatment for Serratia marcescens corneal ulcer. American journal of ophthalmology, 231e1-e2. https://doi.org/10.1016/j.ajo.2021.07.007
Levine, Harry, et al. "Rose Bengal Photodynamic Antimicrobial Therapy as potential adjuvant treatment for Serratia marcescens corneal ulcer." American journal of ophthalmology vol. 231 (2021): e1-e2. doi: https://doi.org/10.1016/j.ajo.2021.07.007
Levine H, Sepulveda-Beltran PA, Amescua G. Rose Bengal Photodynamic Antimicrobial Therapy as potential adjuvant treatment for Serratia marcescens corneal ulcer. Am J Ophthalmol. 2021 Nov;231:e1-e2. doi: 10.1016/j.ajo.2021.07.007. Epub 2021 Jul 17. PMID: 34283981.
Copy Download .nbib Format: NLM
Share it on

Am J Ophthalmol. 2021 Nov;231:e1-e2. doi: 10.1016/j.ajo.2021.07.007. Epub 2021 Jul 17.

Rose Bengal Photodynamic Antimicrobial Therapy as potential adjuvant treatment for Serratia marcescens corneal ulcer.

American journal of ophthalmology

Harry Levine, Paula A Sepulveda-Beltran, Guillermo Amescua

Affiliations

  1. Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
  2. Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA. Electronic address: [email protected].

PMID: 34283981 DOI: 10.1016/j.ajo.2021.07.007

[No abstract available.]

Conflict of interest statement

Conflicts of interest Guillermo Amescua is part holder of the patent for the design of the light-source used in the treatment of this patent. The other authors have no conflicts of interest to disclos

Publication Types